Search Results - "Kosar, Hana"

Safety and efficacy of pyrotinib in patients with NSCLC and other advanced solid tumors with activating HER2 alterations: A phase I basket trial by Li, Bob T., Li, Tianhong, Johnson, Melissa Lynne, Waqar, Saiama Naheed, Zhu, Viola Weijia, Ou, Sai-Hong Ignatius, Lin, Jessica Jiyeong, Wang, Ding, Shapiro, Geoffrey, Wang, Judy Sing-Zan, Liu, Dazhi, Ye, Yuqing, Kosar, Hana, Hee, Angela, Berk, Greg, Zhang, Sean, Wang, Junsheng, Patel, Manish R.

“…Abstract only 3510 Background: Pyrotinib is a potent, irreversible tyrosine kinase inhibitor (TKI) that blocks signal transduction through the erythroblastic…”
Get full text

Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder by Steiner, Meir, Allgulander, Christer, Ravindran, Arun, Kosar, Hana, Burt, Tal, Austin, Carol

“…Objective To evaluate gender differences in the clinical presentation of generalized anxiety disorder (GAD) and response to sertraline treatment. Methods Adult…”
Get full text